Dr. Gertel has more than 40 years of experience in the pharmaceutical industry in virtually all phases of pharmaceutical drug research and development, from preclinical pathology/toxicology to registrational clinical trials, post-marketing trials, project management, and market support. He has been involved in the development of standards in reporting clinical trial data, publications, and protocol development. He leads seminars and panels on drug development and bioethics.